The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator
Abstract
Objective: To assess the effects of the prescription formulation of glucosamine sulfate (1,500 mg administered once daily) on the symptoms of knee osteoarthritis (OA) during a 6‐month treatment course. Methods: Three hundred eighteen patients were enrolled in this randomized, placebo‐controlled, double‐blind trial in which acetaminophen, the currently preferred medication for symptomatic treatment of OA, was used as a side comparator. Patients were randomly assigned to receive oral glucosamine sulfate 1,500 mg once daily (n = 106), acetaminophen 3 gm/day (n = 108), or placebo (n = 104). The primary efficacy outcome measure was the change in the Lequesne index after 6 months. Secondary parameters included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and response according to the Osteoarthritis Research Society International criteria. These outcome measures were assessed using an intent‐to‐treat analysis. Results: At baseline, the study patients had moderately severe OA symptoms (mean Lequesne index ∼11 points). Glucosamine sulfate was more effective than placebo in improving the Lequesne score, with a final decrease of 3.1 points, versus 1.9 with placebo (difference between glucosamine sulfate and placebo −1.2 [95% confidence interval −2.3, −0.8]) (P = 0.032). The 2.7‐point decrease with acetaminophen was not significantly different from that with placebo (difference −0.8 [95% confidence interval −1.9, 0.3]) (P = 0.18). Similar results were observed for the WOMAC. There were more responders to glucosamine sulfate (39.6%) and acetaminophen (33.3%) than to placebo (21.2%) (P = 0.004 and P = 0.047, respectively, versus placebo). Safety was good, and was comparable among groups. Conclusion: The findings of this study indicate that glucosamine sulfate at the oral once‐daily dosage of 1,500 mg is more effective than placebo in treating knee OA symptoms. Although acetaminophen also had a higher responder rate compared with placebo, it failed to show significant effects on the algofunctional indexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiological Assessment of Osteo-Arthrosis
Kellgren, J. H., & Lawrence, J. S. (1957) · Annals of the Rheumatic Diseases · doi:10.1136/ard.16.4.494 · Cited by 12,422
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Self-citationRecommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052771 · Cited by 1,329
Reginster, J. Y., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyere, O., Giacovelli, G., Henrotin, Y., Dacre, J. E., & Gossett, C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03610-2 · Cited by 1,234
Tubach, F., Ravaud, P., Baron, G., Falissard, B., Logeart, I., Bellamy, N., Bombardier, C., Felson, D., Hochberg, M., van der Heijde, D., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.022905 · Cited by 1,094
Clinical trials: A practical approach
Daly, M. J. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90515-7 · Cited by 1,053
McAlindon, T. E., LaValley, M. P., Gulin, J. P., & Felson, D. T. (2000) · JAMA · doi:10.1001/jama.283.11.1469 · Cited by 849
Lequesne, M. G., Mery, C., Samson, M., & Gerard, P. (1987) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748709102182 · Cited by 786
Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., & Rovati, L. C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2113 · Cited by 683
Glucosamine therapy for treating osteoarthritis
Towheed, T., Maxwell, L., Anastassiades, T. P., Shea, B., Houpt, J., Welch, V., Hochberg, M. C., & Wells, G. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002946.pub2 · Cited by 659
Tubach, F., Ravaud, P., Baron, G., Falissard, B., Logeart, I., Bellamy, N., Bombardier, C., Felson, D., Hochberg, M., van der Heijde, D., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023028 · Cited by 640
Altman, R., Brandt, K., Hochberg, M., Moskowitz, R., Bellamy, N., Bloch, D. A., Buckwalter, J., Dougados, M., Ehrlich, G., Lequesne, M., et al. (1996) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80101-3 · Cited by 577
Acetaminophen for osteoarthritis
Towheed, T., Maxwell, L., Judd, M., Catton, M., Hochberg, M. C., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004257.pub2 · Cited by 563
Osteoarthritis: New Insights. Part 2: Treatment Approaches
Felson, D. T., Lawrence, R. C., Hochberg, M. C., McAlindon, T., Dieppe, P. A., Minor, M. A., Blair, S. N., Berman, B. M., Fries, J. F., Weinberger, M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00015 · Cited by 506
Bjordal, J. M., Ljunggren, A. E., Klovning, A., & Slørdal, L. (2004) · BMJ · doi:10.1136/bmj.38273.626655.63 · Cited by 454
Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes
Largo, R., Alvarez-Soria, M. A., Dı́ez-Ortego, I., Calvo, E., Sánchez-Pernaute, O., Egido, J., & Herrero-Beaumont, G. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00028-1 · Cited by 386
Self-citationRichy, F., Bruyere, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1514 · Cited by 368
James Williams, H., Ward, J. R., Egger, M. J., Neuner, R., Brooks, R. H., Clegg, D. O., Field, E. H., Skosey, J. L., Alarcón, G. S., Willkens, R. F., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360904 · Cited by 262
García Rodríguez, L. A., & Hernández-Díaz, S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar146 · Cited by 236
Practical Guidelines for Multiplicity Adjustment in Clinical Trials
Proschan, M. A., & Waclawiw, M. A. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00106-9 · Cited by 225
Index of severity for osteoarthritis of the hip and knee
Lequesne, M. G. (1987) · Scandinavian Journal of Rheumatology · Cited by 190
Dougados, M., Leclaire, P., van der Heijde, D., Bloch, D. A., Bellamy, N., & Altman, R. D. (2000) · Osteoarthritis and Cartilage · doi:10.1053/joca.2000.0361 · Cited by 186
Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee.
Houpt, J. B., McMillan, R., Wein, C., & Paget-Dellio, S. D. (1999) · PubMed · Cited by 184
Guidelines for testing slow acting drugs in osteoarthritis.
Lequesne, M., Brandt, K. D., Bellamy, N., Moskowitz, R. W., Menkes, C. J., Pelletier, J., & Altman, R. D. (1994) · PubMed · Cited by 180
Persiani, S., Roda, E., Rovati, L. C., Locatelli, M., Giacovelli, G., & Roda, A. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.07.009 · Cited by 179
McAlindon, T., Formica, M., LaValley, M., Lehmer, M., & Kabbara, K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.023 · Cited by 158
Cibere, J., Kopec, J. A., Thorne, A., Singer, J., Canvin, J., Robinson, D., Pope, J. E., Hong, P., Grant, E., & Esdaile, J. M. (2004) · Arthritis Care & Research · doi:10.1002/art.20697 · Cited by 138
Active ingredient consistency of commercially available glucosamine sulfate products.
RUSSELL, A. S., Aghazadeh‐Habashi, A., & Jamali, F. (2002) · PubMed · Cited by 104
Biggee, B. A., Blinn, C. M., McAlindon, T. E., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036368 · Cited by 96
Temple, A. R., Benson, G. D., Zinsenheim, J. R., & Schweinle, J. E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.02.004 · Cited by 86
Nutritional Supplements for Knee Osteoarthritis — Still No Resolution
Hochberg, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejme058324 · Cited by 57
Why are clinical trials of glucosamine no longer uniformly positive?
McAlindon, T. E. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00064-4 · Cited by 50
Cordoba, F., & Nimni, M. E. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(02)00351-5 · Cited by 47
(1988) · PubMed
Cited by
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
OARSI recommendations for the management of hip and knee osteoarthritis
Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.013 · Cited by 1,700
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.06.014 · Cited by 796
Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Curtis, E. M., Al-Daghri, N. M., Herrero-Beaumont, G., Martel-Pelletier, J., Pelletier, J.-P., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.04.008 · Cited by 695
Self-citationGlucosamine therapy for treating osteoarthritis
Towheed, T., Maxwell, L., Anastassiades, T. P., Shea, B., Houpt, J., Welch, V., Hochberg, M. C., & Wells, G. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002946.pub2 · Cited by 659
Metadata
- Authors
- Herrero‐Beaumont, G., Ivorra, J. A. R., del Carmen Trabado, M., Blanco, F. J., Benito, P., Martín‐Mola, E., Paulino, J., Marenco, J. L., Porto, A., Laffon, A., Araújo, D., Figueroa, M., & Branco, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-01-30
- Volume
- 56
- Issue
- 2
- Pages
- 555-567
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2074339153
- Cited by
- 287
- References
- 41
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.